Accenture buys strategy and consulting firm Bionest

Feb. 02, 2023 11:21 AM ETAccenture plc (ACN)By: Preeti Singh, SA News Editor
  • Accenture (NYSE:ACN) has acquired strategy and consulting firm Bionest to expand its strategy capabilities in life sciences.
  • Terms of the transaction were not disclosed.
  • Headquartered in New York with a European office in Paris, Bionest's team of 46 scientifically-minded consultants, industry executives, and specialists will join Accenture Strategy in the Life Sciences practice.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.